These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression. Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180 [TBL] [Abstract][Full Text] [Related]
10. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. Eiseler T; Schmid MA; Topbas F; Pfizenmaier K; Hausser A FEBS Lett; 2007 Sep; 581(22):4279-87. PubMed ID: 17707375 [TBL] [Abstract][Full Text] [Related]
11. Differential requirement for RhoA GTPase depending on the cellular localization of protein kinase D. Mullin MJ; Lightfoot K; Marklund U; Cantrell DA J Biol Chem; 2006 Sep; 281(35):25089-96. PubMed ID: 16772297 [TBL] [Abstract][Full Text] [Related]
12. Murine models of polycystic kidney disease: molecular and therapeutic insights. Guay-Woodford LM Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027 [TBL] [Abstract][Full Text] [Related]
13. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest. Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. Dirkx E; Cazorla O; Schwenk RW; Lorenzen-Schmidt I; Sadayappan S; Van Lint J; Carrier L; van Eys GJ; Glatz JF; Luiken JJ Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H323-31. PubMed ID: 22636676 [TBL] [Abstract][Full Text] [Related]
15. Loss of protein kinase D activity demonstrates redundancy in cardiac glucose metabolism and preserves cardiac function in obesity. De Jong KA; Hall LG; Renton MC; Connor T; Martin SD; Kowalski GM; Shaw CS; Bruce CR; Howlett KF; McGee SL Mol Metab; 2020 Dec; 42():101105. PubMed ID: 33099046 [TBL] [Abstract][Full Text] [Related]
16. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1. Liu G; Kang X; Guo P; Shang Y; Du R; Wang X; Chen L; Yue R; Kong F Ren Fail; 2020 Nov; 42(1):333-342. PubMed ID: 32340512 [TBL] [Abstract][Full Text] [Related]
17. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. Woo DD; Nguyen DK; Khatibi N; Olsen P J Clin Invest; 1997 Oct; 100(8):1934-40. PubMed ID: 9329956 [TBL] [Abstract][Full Text] [Related]
18. The effect of paclitaxel on the progression of polycystic kidney disease in rodents. Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221 [TBL] [Abstract][Full Text] [Related]
19. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse. Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651 [TBL] [Abstract][Full Text] [Related]
20. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. Matthews SA; Rozengurt E; Cantrell D J Biol Chem; 1999 Sep; 274(37):26543-9. PubMed ID: 10473617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]